Author:
Paranjape Neha,Lin Yu-Hsiu T.,Flores-Ramirez Quetzal,Sarin Vishesh,Johnson Amanda Brooke,Chu Julia,Paredes Mercedes,Wiita Arun P.
Abstract
Abstract22q11.2 deletion syndrome, associated with congenital and neuropsychiatric anomalies, is the most common copy number variant (CNV)-associated syndrome. Patient-derived, induced pluripotent stem cell (iPS) models have provided insight into this condition. However, patient-derived iPS cells may harbor underlying genetic heterogeneity that can confound analysis. Furthermore, almost all available models reflect the commonly-found ~ 3 Mb “A-D” deletion at this locus. The ~ 1.5 Mb “A-B” deletion, a variant of the 22q11.2 deletion which may lead to different syndromic features, and is much more frequently inherited than the A-D deletion, remains under-studied due to lack of relevant models. Here we leveraged a CRISPR-based strategy to engineer isogenic iPS models of the 22q11.2 “A-B” deletion. Differentiation to excitatory neurons with subsequent characterization by transcriptomics and cell surface proteomics identified deletion-associated alterations in proliferation and adhesion. To illustrate in vivo applications of this model, we further implanted neuronal progenitor cells into the cortex of neonatal mice and found potential alterations in neuronal maturation. The isogenic models generated here will provide a unique resource to study this less-common variant of the 22q11.2 microdeletion syndrome.
Funder
Roberta and Oscar Gregory Endowment in Stroke and Brain Research
National Institute of Neurological Disorders and Stroke
Doris Duke Charitable Foundation
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Burnside, R. D. 22q11.21 deletion syndromes: A review of proximal, central, and distal deletions and their associated features. Cytogenet. Genome Res. 146, 89–99. https://doi.org/10.1159/000438708 (2015).
2. McDonald-McGinn, D. M. et al. 22q11.2 deletion syndrome. Nat. Rev. Dis. Primers 1, 15071. https://doi.org/10.1038/nrdp.2015.71 (2015).
3. Panamonta, V. et al. Birth prevalence of chromosome 22q11.2 deletion syndrome: A systematic review of population-based studies. J. Med. Assoc. Thai 99(Suppl 5), S187-193 (2016).
4. Monks, S. et al. Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome. Schizophr. Res. 153, 231–236. https://doi.org/10.1016/j.schres.2014.01.020 (2014).
5. Vorstman, J. A. S. et al. The 22q11.2 deletion in children: High rate of autistic disorders and early onset of psychotic symptoms. J. Am. Acad. Child Adolesc. Psychiatry 45, 1104–1113. https://doi.org/10.1097/01.chi.0000228131.56956.c1 (2006).